139 related articles for article (PubMed ID: 8412748)
1. Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency.
Brusilow SW; Finkelstien J
Metabolism; 1993 Oct; 42(10):1336-9. PubMed ID: 8412748
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels.
Jiang Y; Almannai M; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2017 Nov; 122(3):39-45. PubMed ID: 28888854
[TBL] [Abstract][Full Text] [Related]
3. Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.
Marini JC; Lanpher BC; Scaglia F; O'Brien WE; Sun Q; Garlick PJ; Jahoor F; Lee B
Am J Clin Nutr; 2011 Jun; 93(6):1248-54. PubMed ID: 21490144
[TBL] [Abstract][Full Text] [Related]
4. In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.
Yudkoff M; Daikhin Y; Nissim I; Jawad A; Wilson J; Batshaw M
J Clin Invest; 1996 Nov; 98(9):2167-73. PubMed ID: 8903337
[TBL] [Abstract][Full Text] [Related]
5. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion.
Brusilow SW
Pediatr Res; 1991 Feb; 29(2):147-50. PubMed ID: 2014149
[TBL] [Abstract][Full Text] [Related]
6. Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.
Mokhtarani M; Diaz GA; Rhead W; Lichter-Konecki U; Bartley J; Feigenbaum A; Longo N; Berquist W; Berry SA; Gallagher R; Bartholomew D; Harding CO; Korson MS; McCandless SE; Smith W; Vockley J; Bart S; Kronn D; Zori R; Cederbaum S; Dorrani N; Merritt JL; Sreenath-Nagamani S; Summar M; Lemons C; Dickinson K; Coakley DF; Moors TL; Lee B; Scharschmidt BF
Mol Genet Metab; 2012 Nov; 107(3):308-14. PubMed ID: 22958974
[TBL] [Abstract][Full Text] [Related]
7. Prenatal treatment of ornithine transcarbamylase deficiency.
Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
[TBL] [Abstract][Full Text] [Related]
8. Dietary arginine deficiency and gut ammonium infusion alter flux of urea cycle intermediates across the portal-drained viscera of pigs.
Prior RL; Gross KL
J Nutr; 1995 Feb; 125(2):251-63. PubMed ID: 7861252
[TBL] [Abstract][Full Text] [Related]
9. Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis.
Brusilow SW
J Clin Invest; 1984 Dec; 74(6):2144-8. PubMed ID: 6511918
[TBL] [Abstract][Full Text] [Related]
10. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
Scaglia F; Carter S; O'Brien WE; Lee B
Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of girls with ornithine transcarbamylase deficiency.
Maestri NE; Brusilow SW; Clissold DB; Bassett SS
N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
[TBL] [Abstract][Full Text] [Related]
12. Ornithine restores ureagenesis capacity and mitigates hyperammonemia in Otc(spf-ash) mice.
Marini JC; Lee B; Garlick PJ
J Nutr; 2006 Jul; 136(7):1834-8. PubMed ID: 16772445
[TBL] [Abstract][Full Text] [Related]
13. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency.
Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW
Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602
[TBL] [Abstract][Full Text] [Related]
14. Excretion of excess nitrogen and increased survival by loss of SLC6A19 in a mouse model of ornithine transcarbamylase deficiency.
Belanger AJ; Gefteas E; Przybylska M; Geller S; Anarat-Cappillino G; Kloss A; Yew NS
J Inherit Metab Dis; 2023 Jan; 46(1):55-65. PubMed ID: 36220785
[TBL] [Abstract][Full Text] [Related]
15. In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle.
Lee B; Yu H; Jahoor F; O'Brien W; Beaudet AL; Reeds P
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8021-6. PubMed ID: 10869432
[TBL] [Abstract][Full Text] [Related]
16. Differential utilization of systemic and enteral ammonia for urea synthesis in control subjects and ornithine transcarbamylase deficiency carriers.
Scaglia F; Marini J; Rosenberger J; Henry J; Garlick P; Lee B; Reeds P
Am J Clin Nutr; 2003 Oct; 78(4):749-55. PubMed ID: 14522733
[TBL] [Abstract][Full Text] [Related]
17. Urea synthesis in enterocytes of developing pigs.
Wu G
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):717-23. PubMed ID: 8554511
[TBL] [Abstract][Full Text] [Related]
18. Ammonia toxicity and its prevention in inherited defects of the urea cycle.
Walker V
Diabetes Obes Metab; 2009 Sep; 11(9):823-35. PubMed ID: 19531057
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult and pediatric patients with urea cycle disorders.
Monteleone JP; Mokhtarani M; Diaz GA; Rhead W; Lichter-Konecki U; Berry SA; Lemons C; Dickinson K; Coakley D; Lee B; Scharschmidt BF
J Clin Pharmacol; 2013 Jul; 53(7):699-710. PubMed ID: 23775211
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects.
Nagasaka H; Tsukahara H; Yorifuji T; Miida T; Murayama K; Tsuruoka T; Takatani T; Kanazawa M; Kobayashi K; Okano Y; Takayanagi M
Metabolism; 2009 Mar; 58(3):278-82. PubMed ID: 19217439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
